PDCD1 and small cell lung carcinoma: T cell immunoreceptor with Ig and immunoreceptor tyrosine‐based inhibition motif domains (TIGIT) inhibitors combined with PD-1 inhibitors have been used to treat small cell lung cancer (SCLC) (10).